Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Monica K Sikka"'
Autor:
Amber C. Streifel, Jose Eduardo Rivera Sarti, Monica K. Sikka, Michael Conte, Bradie Winders, Cara D. Varley
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 11 (2024)
Background: Rates of serious injection-related infections in persons who use drugs have increased. Resulting admissions are an opportunity for screening and vaccination of preventable infections such as hepatitis A virus (HAV), hepatitis B virus (HBV
Externí odkaz:
https://doaj.org/article/f5b080d6cc66454da9f914211b97b844
Autor:
Amy Eckland, Michael Kohut, Henry Stoddard, Deb Burris, Frank Chessa, Monica K. Sikka, Daniel A. Solomon, Colleen M. Kershaw, Ellen F. Eaton, Rebecca Hutchinson, Peter D. Friedmann, Thomas J. Stopka, Kathleen M. Fairfield, Kinna Thakarar
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Background: People who inject drugs (PWID) are at risk for severe bacterial and fungal infections including skin and soft tissue infections, endocarditis, and osteomyelitis. PWID have high rates of self-directed discharge and are often not offered ou
Externí odkaz:
https://doaj.org/article/75b62333a5c14e59bc2b3f8905b75bda
Autor:
Alyse H. Douglass, Heather Mayer, Kathleen Young, Monica K. Sikka, Luke Strnad, Jina Makadia, Ellie Sukerman, James S. Lewis, Amber C. Streifel
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Background: Serious infections in persons who use drugs (PWUD) are rising. Dalbavancin, due to its extended half-life, offers an alternative treatment for patients in whom standard of care antibiotics are not feasible or practical, allowing for reduc
Externí odkaz:
https://doaj.org/article/fce8e939a9294723a8bd4d7f7ce73273
Autor:
Kinna Thakarar, Michael Kohut, Henry Stoddard, Deb Burris, Frank Chessa, Monica K. Sikka, Daniel A. Solomon, Colleen M. Kershaw, Ellen Eaton, Rebecca Hutchinson, Kathleen M. Fairfield, Peter Friedmann, Thomas J. Stopka
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Background: The prevalence of injection drug use (IDU)-associated infections and associated hospitalizations has been increasing for nearly two decades. Due to issues ranging from ongoing substance use to peripherally inserted central catheter safety
Externí odkaz:
https://doaj.org/article/863a25ee622b49c68cdec9fc7ceebad9
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Corynebacterium striatum is a gram-positive facultative anaerobe found in the environment and human flora that has historically been considered a contaminant. More recently, Corynebacterium striatum has been implicated in human in
Externí odkaz:
https://doaj.org/article/0143416815674e5893716b854479168e
Autor:
Gaurav Agnihotri, Alan E. Gross, Minji Seok, Cheng Yu Yen, Farah Khan, Laura M. Ebbitt, Cassandra Gay, Susan C. Bleasdale, Monica K. Sikka, Andrew B. Trotter
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: To determine whether a structured OPAT program supervised by an infectious disease physician and led by an OPAT nurse decreased hospital readmission rates and OPAT-related complications and whether it affected clinical cure. We a
Externí odkaz:
https://doaj.org/article/e872d1fd7a4b4ffc97913fbe8abe65a5
Autor:
Nichole Moore, Michael Kohut, Henry Stoddard, Debra Burris, Frank Chessa, Monica K. Sikka, Daniel Solomon, Colleen M. Kershaw, Ellen Eaton, Rebecca Hutchinson, Kathleen M. Fairfield, Thomas J. Stopka, Peter Friedmann, Kinna Thakarar
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 9 (2022)
Background: Patients with injection drug use (IDU)-associated infections traditionally experience prolonged hospitalizations, which often result in negative experiences and bad outcomes. Harm reduction approaches that value patient autonomy and share
Externí odkaz:
https://doaj.org/article/950fd81fe8714328b909e51c1996eb36
Screening for co-infections in patients with substance use disorders and severe bacterial infections
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 9 (2022)
Background: Patients with substance use disorders admitted for severe bacterial infection are in a prime position to be screened for important co-infections. However, data suggest that standard screening for co-infections in this population during ho
Externí odkaz:
https://doaj.org/article/c9ea9cc1963b4adcbc0173ef5ea46583
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Serious bacterial infections associated with substance use often result in long hospitalizations, premature discharges, and high costs. Out-of-hospital treatment options in people with substance use disorder (SUD) are often limite
Externí odkaz:
https://doaj.org/article/5b6717ac000c41e2bca5a306e95b4a71
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 9 (2022)
Background: Patients with substance use disorders (SUDs) and severe bacterial infections requiring prolonged antibiotic therapy represent a significant challenge to providers due to complexity of care coordination required to ensure safe and effectiv
Externí odkaz:
https://doaj.org/article/e281a14229114c669d1bc40a1b167cf2